Congress should encourage companies to repurpose existing drugs for rare diseases, potentially doubling the number of treatment options for patients. Lately, there has been a national uproar over the rising cost of medicine in the U.S. While this is an important public debate, it largely overlooks the critical importance of innovation, which is desperately needed […]
